Article
Publicly Available
Frontmatter
Published/Copyright:
September 23, 2016
Published Online: 2016-9-23
Published in Print: 2016-9-1
©2016 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review
- Pharmacogenomics in pain treatment
- Original Articles
- Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH −1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence
- Medication therapy management (MTM): an innovative approach to improve medication adherence in diabetics
- Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen?
- Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease
- The impact of CYP4F2, ABCB1, and GGCX polymorphisms on bleeding episodes associated with acenocoumarol in Russian patients with atrial fibrillation
Articles in the same Issue
- Frontmatter
- Review
- Pharmacogenomics in pain treatment
- Original Articles
- Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH −1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence
- Medication therapy management (MTM): an innovative approach to improve medication adherence in diabetics
- Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen?
- Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease
- The impact of CYP4F2, ABCB1, and GGCX polymorphisms on bleeding episodes associated with acenocoumarol in Russian patients with atrial fibrillation